About
William F. Feehery, Ph.D., served as Chief Executive Officer of Certara from June 2019 until the end of 2025, when he entered a separation and consulting agreement and was succeeded by Jon Resnick effective January 1, 2026; he also served on the board from 2019. Before Certara he was President of DuPont Industrial Biosciences from 2013 to 2019, having joined DuPont in 2002, with earlier experience in venture capital and at The Boston Consulting Group. He holds a Ph.D. in chemical engineering and an MBA from MIT, was a Churchill Scholar at Cambridge University, and has served on the board of West Pharmaceutical Services.
Roles
Certara, Inc.
Former Chief Executive Officer · Current role
2019–present
DuPont Industrial Biosciences
President (2013-2019)
—
DuPont
Operating roles in high-growth businesses (from 2002)
—
The Boston Consulting Group
Consultant
—
External Roles
West Pharmaceutical Services, Inc.
Director
—
Winston Churchill Foundation of the United States
Trustee
—
Fixed Compensation
FY 2025Salary
$795,675
ComponentAnnual base salary
All other compensation
$20,275
Component401(k) match, insurance and perquisites
Total compensation
$6,491,387
Performance Compensation
Data from FY 2025Cash incentive
Annual incentive bonus
$747,935
FormCash
Target Opportunity
—
PlanAnnual Incentive Bonus (AIB) Plan
Evaluation periodFY2025
Stock awards
Long-term equity awards
$4,927,502
FormRSUs (40%) and PSUs (60%) under 2020 Incentive Plan
ValuationGrant date fair value (ASC 718), PSUs at target
Also at Certara, Inc.
See how Top Bucket AI works for your firm
Request DemoTop Bucket AI Research
Stay ahead of private markets
Research and market intelligence for private-markets professionals.
✓
You're subscribed.
Thanks for signing up.